Abstract

The single and comparative intradermal tuberculin (SIT and CIT) tests are used for the ante-mortem diagnosis of caprine tuberculosis (TB). The tuberculin injection site has been associated with a different performance of the test in cattle. In contrast to that required in cattle in Europe (cervical injection), it can be carried out in the scapular region in goats. Nevertheless, there are no previous data concerning the effect of the injection site on the performance of the test in goats. The aim of the present study was to evaluate the effect of two different inoculation sites (cervical and scapular) on the performance of the SIT/CIT tests. This was done by intradermally inoculating 309 goats from two infected herds and one TB-free herd with both avian and bovine PPDs in the mid-cervical and scapular regions. None of the animals from the TB-free herd had positive reactions, and the number of reactors was not significantly higher, regardless of the inoculation site, in the high and low prevalence herds. However, significantly higher increases in skin fold thickness were observed on the cervical site when compared to the scapular site after the avian and bovine PPD inoculations in the TB-free herd (p < 0.001) and after the bovine PPD injection in the high prevalence herd (p = 0.003). The presence of clinical signs was also more evident on the cervical site when using avian and bovine PPDs in the high prevalence herd (p < 0.01). In contrast, increases in higher skin fold thickness were observed on the scapular site when compared to the cervical site after the bovine and avian PPD inoculations were employed in the low prevalence herd (p < 0.01). These results suggest that the cervical injection of PPDs may improve the sensitivity of the intradermal tuberculin test in high TB prevalence caprine herds, mainly owing to the increased presence of local clinical signs and a better performance of the CIT test. Moreover, specificity was not affected when using standard interpretations, although further analyses in a great number of herds are required in order to confirm these findings.

Highlights

  • Tuberculosis (TB) is a zoonotic infection disease caused by members of the Mycobacterium tuberculosis complex (MTBC) [1] that affects humans and a wide range of wild and domestic animals [2,3,4]

  • The aim of the present study was, to carry out the first documented evaluation of whether the PPD inoculation site has an effect on the performance of the SIT and CIT tests when used with goats

  • Ninety-six adult goats were randomly selected from the high prevalence herd, 94 from the low prevalence herd, and 119 from the TB-free herd, and all animals were subjected to the intradermal tests and interferongamma release assay (IGRA)

Read more

Summary

Introduction

Tuberculosis (TB) is a zoonotic infection disease caused by members of the Mycobacterium tuberculosis complex (MTBC) [1] that affects humans and a wide range of wild and domestic animals [2,3,4]. Caprine TB is caused principally by Mycobacterium bovis and Mycobacterium caprae [5, 6], with the latter being the main etiological agent in Spain [7]. The Spanish bovine TB eradication programme recommends the testing of goats that have any epidemiological link with cattle [9]. Certain regions of Spain carry out specific TB control programmes on caprine herds. As occurs with the bovine TB eradication programme, TB eradication programmes in goats are based principally on a test and cull strategy carried out using the single and comparative intradermal tuberculin (SIT and CIT) tests and slaughterhouse surveillance [10]. The interferongamma release assay (IGRA), which is an official ancillary test for TB diagnosis in cattle, is not, routinely used with goats [10,11,12,13]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call